Melasma
☆ AI Dermatology — Free Service
In i risultati Stiftung Warentest 2022 da Germania, a satisfaczione di i cunsumatori cù ModelDerm era solu ligeramente più bassu chè cù cunsultazioni di telemedicina pagate.
In i risultati Stiftung Warentest 2022 da Germania, a satisfaczione di i cunsumatori cù ModelDerm era solu ligeramente più bassu chè cù cunsultazioni di telemedicina pagate.
Hè una condizione cumuna osservata in e donne asiatiche trà i primi 40 anni. A lesione mostrata in a foto hè più vicina à lentigo chì à melasma.
relevance score : -100.0%
ReferencesTranexamic acid is a novel treatment option for melasma; however, there is no consensus on its use. This systematic review searched major databases for relevant publications to March 2016. Eleven studies with 667 participants were included. Pooled data from tranexamic acid-only observational studies with pre- and post-treatment Melasma Area and Severity Index (MASI) showed a decrease of 1.60 in MASI after treat?ment with tranexamic acid. The addition of tranexamic acid to routine treatment modalities resulted in a further decrease in MASI of 0.94. These results support the efficacy and safety of tranexamic acid, either alone or as an adjuvant to routine treatment modalities for melasma.
Ricertamenti, low-fluence Q-switched Nd:YAG (LFQSNY) laser hè diventatu populari per trattà u melasma, in particulare in Asia. Riassuntu diversi studii era sfida, ma LFQSNY pare in generale efficace è sicuru per u melasma cumparatu cù e terapie tradiziunali. In ogni casu, certi casi di ipopigmentazione mottled sò stati rappurtati cum'è un effettu secundariu di LFQSNY, possibbilmente per l'alta energia laser. L'usu aggressivu di LFQSNY pò ancu guidà à l'iperpigmentazione da a inflamazioni, particularmente in i toni di a pelle scura.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
Recently, the low-fluence Q-switched Nd:YAG laser (LFQSNY) has been widely used for treating melasma, especially in Asia. It was hard to summarize the heterogenous studies, but LFQSNY appeared to be a generally effective and safe treatment for melasma considering the results of previous conventional therapies. However, mottled hypopigmentation has been occasionally reported to develop and persist as an adverse event of LFQSNY, which may be associated with the high accumulated laser energy. When used aggressively, even LFQSNY can induce hyperpigmentation via unwanted inflammation, especially in darker skin.
I prublemi di pigmentazione sò spessu truvati in l'assistenza primaria. I tipi cumuni di disturbi d’iperpigmentazione includenu post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Pigmentation problems are often found in primary care. Common types of hyperpigmentation disorders include post-inflammatory hyperpigmentation, melasma, sunspots, freckles, café au lait spots.
Melasma ùn pò esse risoltu cù trattamentu laser per un certu periodu di tempu, postu chì hè una cundizione in cui u pigmentu hè pruduttu continuamente. L’acidu tranexamicu aiuta à migliurà è à riduce a pigmentazione.
○ Trattamentu
In certi paesi (per esempiu, Giappone, Corea), l’acidu tranexamicu orale hè dispunibule in farmacia è hè efficace. A crema per melasma cun acidu tranexamicu è acidu azelaicu pò esse parzialmente utile.
L’idrochinone pò esse adupratu per u trattamentu di l’iperpigmentazione, ma a FDA hà ritiratu i prudutti OTC chì cuntenenu idrochinone dal 2020.
#Tranexamic acid [TRANSINO]
#Laser toning technique (low fluence QS1064 laser)
#Triluma